Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.43 CAD | +2.53% | -14.74% | +478.57% |
Sales 2024 * | - | Sales 2025 * | 500K 363K | Capitalization | 183M 133M |
---|---|---|---|---|---|
Net income 2024 * | -15M -10.89M | Net income 2025 * | -19M -13.79M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 366 x |
P/E ratio 2024 * |
-11
x | P/E ratio 2025 * |
-9.72
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.81% |
Latest transcript on Medicenna Therapeutics Corp.
1 day | +2.53% | ||
1 week | -14.74% | ||
Current month | -14.74% | ||
1 month | -7.25% | ||
3 months | +109.48% | ||
6 months | +434.07% | ||
Current year | +478.57% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11-09-30 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
David Hyman
DFI | Director of Finance/CFO | - | Feb. 13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 19-09-23 |
Albert Beraldo
BRD | Director/Board Member | - | 16-11-21 |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 2.43 | +2.53% | 49,636 |
24-06-06 | 2.37 | -1.66% | 57,525 |
24-06-05 | 2.41 | +1.69% | 176,019 |
24-06-04 | 2.37 | -7.78% | 155,085 |
24-06-03 | 2.57 | -9.82% | 425,374 |
Delayed Quote Toronto S.E., June 07, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+478.57% | 133M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- MDNA Stock